{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:56:20Z","timestamp":1793199380512,"version":"4.5.0"},"reference-count":34,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"unspecified","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"WHO Dr Lee Jong Wook Memorial Prize for Public Health","award":["WHO\/LEEJONGWOOK\/AWARD - JULIE MAKANI"],"award-info":[{"award-number":["WHO\/LEEJONGWOOK\/AWARD - JULIE MAKANI"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2025,1,2]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Despite progress in healthcare services for individuals living with sickle cell disease (SCD) in Africa, substantial gaps remain in advanced treatments for SCD. To help address this burden, Tanzania has established one of the largest single-centre SCD programmes in the world and developed an advanced therapy programme for SCD focused on patient engagement and advocacy, clinical activities involving exchange blood transfusion (ExBT) and haematopoietic stem cell transplant (HSCT), gene therapy (GT) preparedness, and enabling partnerships. This report describes the programme\u2019s genesis, structure and progress achieved. Patient engagement camps and patient-focused workshops conducted since early 2021 have involved more than 150 patients, family caregivers and healthcare providers. A patient registry was established by screening 1500 patients eligible for advanced therapies with 157 identified to benefit from advanced treatments for SCD. Out of which 22 patients received ExBT, and human leucocyte antigen typing was conducted on 127 individuals to establish a registry of family members with potential to be HSCT donors. Target product profiles were devised for minimum and optimum criteria of GT products to guide drug discovery and development efforts, and qualitative research was conducted to investigate factors anticipated to influence successful adoption of GTs for SCD in Africa. The programme\u2019s multifaceted components have been enabled by institutional networks and collaborations established at national, regional and global levels. The programme presented opportunities to deliver cost-effective advanced treatment and curative options for SCD in Tanzania and lessons learnt may be applicable to inform similar efforts in other African regions where SCD is highly endemic.<\/jats:p>","DOI":"10.1136\/bmjgh-2024-017878","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T12:10:19Z","timestamp":1737979819000},"page":"e017878","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Strengthening advanced therapy for sickle cell disease in Africa: experience from sickle cell disease centre in Dar es Salaam, Tanzania"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1376-4654","authenticated-orcid":false,"given":"Daima","family":"Bukini","sequence":"first","affiliation":[{"name":"Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"},{"name":"Johns Hopkins University Berman Institute of Bioethics, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Rifai","sequence":"additional","affiliation":[{"name":"Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin","family":"Kanza","sequence":"additional","affiliation":[{"name":"Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrick","family":"Luoga","sequence":"additional","affiliation":[{"name":"Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deogratius","family":"Maingu","sequence":"additional","affiliation":[{"name":"Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassim","family":"Kassim","sequence":"additional","affiliation":[{"name":"Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Mashaka","sequence":"additional","affiliation":[{"name":"Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eka Patricia","family":"Kisali","sequence":"additional","affiliation":[{"name":"Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salmaan","family":"Karim","sequence":"additional","affiliation":[{"name":"Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Zahir","family":"Alimohamed","sequence":"additional","affiliation":[{"name":"Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"},{"name":"Department of Genetics, University Medical Centre Groningen, Groningen, Netherlands"},{"name":"Tanzania Human Genetics Organization, Dar es salaam, Tanzania"},{"name":"Department of Biochemistry and Molecular Biology, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania"},{"name":"Department of Paediatrics and Child Health, The Aga Khan University, Dar es salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janeth","family":"Manongi","sequence":"additional","affiliation":[{"name":"Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfrida","family":"Lema","sequence":"additional","affiliation":[{"name":"Aga Khan Hospital Dar es Salaam, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison","family":"Chuwa","sequence":"additional","affiliation":[{"name":"Aga Khan Hospital Dar es Salaam, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisawo","family":"Konteh","sequence":"additional","affiliation":[{"name":"Aga Khan Hospital Dar es Salaam, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Urio","sequence":"additional","affiliation":[{"name":"Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"},{"name":"Department of Biochemistry and Molecular Biology, Muhimbili University of Health and Allied Sciences, Dar es salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5508-119X","authenticated-orcid":false,"given":"Irene Kida","family":"Minja","sequence":"additional","affiliation":[{"name":"Restorative Dentistry, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Balandya","sequence":"additional","affiliation":[{"name":"Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Moshi","sequence":"additional","affiliation":[{"name":"Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"},{"name":"KK Women's and Children's Hospital Children's Services, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Makani","sequence":"additional","affiliation":[{"name":"Sickle Cell Programme, Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania"},{"name":"Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"2025072914560216000_10.1.e017878.1","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000\u20132021: a systematic analysis from the Global Burden of Disease Study 2021","volume":"10","author":"Thomson","year":"2023","journal-title":"Lancet Haematol"},{"key":"2025072914560216000_10.1.e017878.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61229-X"},{"key":"2025072914560216000_10.1.e017878.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.10233"},{"key":"2025072914560216000_10.1.e017878.4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00277-015-2573-y","article-title":"Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening","volume":"95","author":"Kunz","year":"2016","journal-title":"Ann Hematol"},{"key":"2025072914560216000_10.1.e017878.5","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/bjh.15600","article-title":"Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference","volume":"183","author":"Lobitz","year":"2018","journal-title":"Br J Haematol"},{"key":"2025072914560216000_10.1.e017878.6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000504144","article-title":"Red Blood Cells: Exchange, Transfuse, or Deplete","volume":"46","author":"Stussi","year":"2019","journal-title":"Transfus Med Hemother"},{"key":"2025072914560216000_10.1.e017878.7","article-title":"Limited Exchange Transfusion Can Be Very Beneficial in Sickle Cell Anemia with Acute Chest Syndrome: A Case Report from Tanzania","volume":"2018","author":"Chamba","year":"2018","journal-title":"Case Rep Hematol"},{"key":"2025072914560216000_10.1.e017878.8","doi-asserted-by":"publisher","DOI":"10.1177\/2040620713483063"},{"key":"2025072914560216000_10.1.e017878.9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/bjh.17106","article-title":"Haematopoietic stem cell transplantation in Tanzania","volume":"192","author":"Mtenga","year":"2021","journal-title":"Br J Haematol"},{"key":"2025072914560216000_10.1.e017878.10","unstructured":"ADMINISTRATION, U. S. F. & D . LYFGENIA. U.S. Food and Drug Administration; 2024. Available: https:\/\/www.fda.gov\/vaccines-blood-biologics\/lyfgenia"},{"key":"2025072914560216000_10.1.e017878.11","unstructured":"U.S. Food and Drug Administration . FDA approves first gene therapies to treat patients with sickle cell disease. U.S. Food and Drug Administration; 2023. Available: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease"},{"key":"2025072914560216000_10.1.e017878.12","unstructured":"Kolata G . First Patient Begins Newly Approved Sickle Cell Gene Therapy. New York Times, 2024:1\u20132."},{"key":"2025072914560216000_10.1.e017878.13","doi-asserted-by":"crossref","unstructured":"Ambrose EE , Makani J , Chami N , et al . High birth prevalence of sickle cell disease in Northwestern Tanzania. Pediatr Blood Cancer 2018;65. doi:10.1002\/pbc.26735","DOI":"10.1002\/pbc.26735"},{"key":"2025072914560216000_10.1.e017878.14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12878-018-0125-0","article-title":"A ten year review of the sickle cell program in Muhimbili National Hospital, Tanzania","volume":"18","author":"Makani","year":"2018","journal-title":"BMC Hematol"},{"key":"2025072914560216000_10.1.e017878.15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/inthealth\/ihz028","article-title":"Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania","volume":"11","author":"Nkya","year":"2019","journal-title":"Int Health"},{"key":"2025072914560216000_10.1.e017878.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014699","article-title":"Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania","volume":"6","author":"Makani","year":"2011","journal-title":"PLoS ONE"},{"key":"2025072914560216000_10.1.e017878.17","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/bjh.14594","article-title":"Sickle cell disease in Africa: an overview of the integrated approach to health, research, education and advocacy in Tanzania, 2004-2016","volume":"177","author":"Tluway","year":"2017","journal-title":"Br J Haematol"},{"key":"2025072914560216000_10.1.e017878.18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/omi.2020.0153","article-title":"The Sickle Cell Disease Ontology: of New Planetary Health Applications","volume":"24","author":"Nembaware","year":"2020","journal-title":"OMICS"},{"key":"2025072914560216000_10.1.e017878.19","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.00943","article-title":"Establishing a Multi-Country Sickle Cell Disease Registry in Africa: Ethical Considerations","volume":"10","author":"Munung","year":"2019","journal-title":"Front Genet"},{"key":"2025072914560216000_10.1.e017878.20","doi-asserted-by":"crossref","DOI":"10.3389\/frhem.2023.1040720","article-title":"Development of the sickle Pan-African research consortium registry in Tanzania: opportunity to harness data science for sickle cell disease","volume":"2","author":"Kandonga","year":"2023","journal-title":"Front Hematol"},{"key":"2025072914560216000_10.1.e017878.21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.hemonc.2019.12.012","article-title":"Curative options for sickle cell disease in Africa: Approach in Tanzania","volume":"13","author":"Makani","year":"2020","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"2025072914560216000_10.1.e017878.22","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbmt.2015.09.012","article-title":"On Modeling Human Leukocyte Antigen-Identical Sibling Match Probability for Allogeneic Hematopoietic Cell Transplantation: Estimating the Need for an Unrelated Donor Source","volume":"22","author":"Besse","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"2025072914560216000_10.1.e017878.23","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.141119"},{"key":"2025072914560216000_10.1.e017878.24","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101287","article-title":"Consensus-driven target product profiles for curative sickle cell disease gene therapies","volume":"32","author":"Bukini","year":"2024","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2025072914560216000_10.1.e017878.25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41586-022-04786-y","article-title":"Clonal dynamics of haematopoiesis across the human lifespan","volume":"606","author":"Mitchell","year":"2022","journal-title":"Nature New Biol"},{"key":"2025072914560216000_10.1.e017878.26","unstructured":"Ministry of Health . National strategic plan for prevention and control of non-communicable diseases 2021-2026 leaving no one behind united republic of Tanzania. 2021."},{"key":"2025072914560216000_10.1.e017878.27","doi-asserted-by":"crossref","first-page":"e565","DOI":"10.1016\/S2352-3026(24)00219-9","article-title":"Update on SickleInAfrica: a collaborative and multidimensional approach to conduct research and improve health","volume":"11","author":"Nkya","year":"2024","journal-title":"Lancet Haematol"},{"key":"2025072914560216000_10.1.e017878.28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41434-021-00284-4","article-title":"Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)","volume":"30","author":"Adair","year":"2023","journal-title":"Gene Ther"},{"key":"2025072914560216000_10.1.e017878.29","doi-asserted-by":"publisher","DOI":"10.1093\/her\/cym045"},{"key":"2025072914560216000_10.1.e017878.30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0738-3991(96)00953-6","article-title":"Effectiveness of health education and health promotion: meta-analyses of effect studies and determinants of effectiveness","volume":"30","author":"Kok","year":"1997","journal-title":"Pat Educ Couns"},{"key":"2025072914560216000_10.1.e017878.31","doi-asserted-by":"crossref","unstructured":"Koloi-Keaikitse S , Kasule M , Kwape I , et al . Understanding cultural values, norms and beliefs that may impact participation in genome-editing related research: Perspectives of local communities in Botswana. Dev World Bioeth 2024. doi:10.1111\/dewb.12440","DOI":"10.1111\/dewb.12440"},{"key":"2025072914560216000_10.1.e017878.32","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adn1902","article-title":"The translational gap for gene therapies in low- and middle-income countries","volume":"16","author":"Doxzen","year":"2024","journal-title":"Sci Transl Med"},{"key":"2025072914560216000_10.1.e017878.33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adn2401","article-title":"Nothing about us without us: Advocacy and engagement in genetic medicine","volume":"16","author":"Olayiwola","year":"2024","journal-title":"Sci Transl Med"},{"key":"2025072914560216000_10.1.e017878.34","unstructured":"ASH . Sickle cell disease transfusion support: a pocket guide for clinicians. 2020."}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2024-017878","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T21:56:10Z","timestamp":1753826170000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2024-017878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,27]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/bmjgh-2024-017878"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2024-017878","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}